Put Options

18 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2023

Feb 02, 2024

SELL
$137.6 - $154.97 $13,760 - $15,497
-100 Reduced 1.33%
7,400 $1.15 Million
Q3 2023

Oct 26, 2023

SELL
$133.59 - $154.65 $160,308 - $185,580
-1,200 Reduced 13.79%
7,500 $1.12 Million
Q2 2023

Aug 08, 2023

SELL
$132.51 - $164.9 $503,537 - $626,620
-3,800 Reduced 30.4%
8,700 $1.17 Million
Q1 2023

May 02, 2023

BUY
$144.61 - $166.54 $997,809 - $1.15 Million
6,900 Added 123.21%
12,500 $1.99 Million
Q4 2022

Jan 23, 2023

BUY
$138.31 - $165.87 $774,536 - $928,872
5,600 New
5,600 $0
Q1 2022

Apr 14, 2022

SELL
$131.98 - $163.75 $329,950 - $409,375
-2,500 Reduced 16.34%
12,800 $6,000
Q2 2021

Jul 26, 2021

BUY
$105.21 - $117.21 $410,319 - $457,119
3,900 Added 34.21%
15,300 $56,000
Q1 2021

Apr 29, 2021

SELL
$102.3 - $112.62 $1.09 Million - $1.21 Million
-10,700 Reduced 48.42%
11,400 $57,000
Q4 2020

Jan 13, 2021

BUY
$80.49 - $108.67 $499,037 - $673,754
6,200 Added 38.99%
22,100 $3,000
Q3 2020

Oct 28, 2020

SELL
$85.91 - $100.83 $17,182 - $20,166
-200 Reduced 1.24%
15,900 $18,000
Q2 2020

Aug 13, 2020

BUY
$73.37 - $98.18 $36,685 - $49,090
500 Added 3.21%
16,100 $27,000
Q1 2020

Apr 09, 2020

SELL
$64.5 - $97.79 $277,350 - $420,497
-4,300 Reduced 21.61%
15,600 $130,000
Q4 2019

Jan 06, 2020

SELL
$72.13 - $90.25 $165,899 - $207,575
-2,300 Reduced 10.36%
19,900 $51,000
Q3 2019

Oct 03, 2019

SELL
$62.98 - $75.72 $12,596 - $15,144
-200 Reduced 0.89%
22,200 $113,000
Q2 2019

Jul 10, 2019

BUY
$65.7 - $83.98 $512,460 - $655,044
7,800 Added 53.42%
22,400 $124,000
Q1 2019

Apr 08, 2019

SELL
$77.14 - $90.79 $61,712 - $72,632
-800 Reduced 5.19%
14,600 $85,000
Q4 2018

Jan 03, 2019

SELL
$77.85 - $96.01 $225,764 - $278,429
-2,900 Reduced 15.85%
15,400 $61,000
Q3 2018

Oct 04, 2018

BUY
$88.91 - $98.84 $1.63 Million - $1.81 Million
18,300 New
18,300 $60,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Xr Securities LLC Portfolio

Follow Xr Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xr Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Xr Securities LLC with notifications on news.